Protein Biology

				Natural Sciences
				Biology
				Molecular Biology
Element	Scope Category	Sub-Item	Definition	Protein Biology
1. Domain	1.1 Scope of the Domain	Boundaries	The range of phenomena the science includes and excludes.	Protein Biology examines the structure, folding, dynamics, interactions, functions, and regulatory roles of proteins. It includes primary-to-quaternary structure, post-translational modifications, enzyme kinetics, and protein–protein/protein–ligand interactions. It excludes DNA/RNA-level information and cellular/organism-level processes except when directly mediated by proteins.
		Scale	The spatial, temporal, or organizational level at which the science operates (e.g., quantum, cellular, social, cosmic).	Operates at atomic, molecular, supramolecular, and cellular scales: amino acids, polypeptide chains, folded domains, complexes, molecular machines, membranes, and cellular protein networks across nanoseconds to functional timescales.
	1.2 Ontological Commitments	Entities	The kinds of things assumed to exist within the domain (particles, organisms, agents, fields, etc.).	Amino acids, polypeptide chains, protein domains, folded structures, protein complexes, enzymes, molecular motors, chaperones, post-translational modifications, cofactors, ligands, substrates, and interaction networks.
		Properties	The fundamental attributes these entities possess (mass, charge, genotype, preference, etc.).	Sequence identity, charge distribution, hydrophobicity, folding stability, catalytic activity, binding affinity, conformational flexibility, allosteric behavior, dynamic transitions, and PTM states.
		Categories	The basic ontological types used to classify domain elements (substances, processes, relations, structures).	Structural classes (α, β, mixed), functional classes (enzymes, receptors, transporters, scaffolds), folding states (native, misfolded, aggregated), interaction types (protein–protein, protein–ligand), and PTM categories (phosphorylation, acetylation, ubiquitination).
	1.3 State-Variables	Variables	The measurable or definable properties that describe system conditions.	Sequence composition, folding state, structural conformation, modification status, binding occupancy, catalytic rate, interaction strength, oligomeric state, and dynamic conformational transitions.
		Parameterization	How variables encode and represent the system’s state.	State represented through sequence data, structural coordinates, folding-energy landscapes, kinetic rate constants, binding-isotherm curves, PTM maps, and interaction-network measurements.
	1.4 Admissible Idealizations	Simplifications	Conceptual reductions used to make the domain tractable (point masses, rational agents, perfect gases).	Treating proteins as rigid bodies, assuming two-state folding, ignoring rare conformational states, modeling interactions with simplified potentials, coarse-graining amino acid behavior, or collapsing PTMs into binary categories.
		Validity Conditions	The limits and contexts in which idealizations hold or break down.	Idealizations fail when proteins exhibit complex folding pathways, multiple conformers, allosteric heterogeneity, crowding-dependent behavior, or when PTMs influence structure/function combinatorially.
	1.5 Domain Assumptions	Structural Assumptions	Background ontological stances such as determinism, continuity, randomness, discreteness.	Assumes that sequence determines structure, structure influences function, biochemical reactions obey consistent kinetic principles, and protein folding follows thermodynamic/kinetic rules.
		Implicit Commitments	Unstated but necessary assumptions that shape the field’s conceptual structure.	Assumes proteins have stable functional states, biochemical environments are reproducible, PTMs carry interpretable signals, and binding interactions follow predictable physical chemistry.
	1.6 Internal Coherence Requirements	Consistency	The demand that domain concepts do not contradict one another.	Sequence–structure–function relationships, folding thermodynamics, dynamic transitions, and interaction behaviors must align without contradicting biochemical or structural principles.
		Compatibility	The requirement that entities, variables, and assumptions fit together into a unified descriptive framework.	Entities (proteins, ligands, modifications), variables (structure, kinetics, stability), and assumptions (sequence–structure mapping, chemical consistency) must fit into a unified mechanistic framework.
2. Evidence Layer	2.1 Observable Phenomena	Observables	The aspects of the domain that can produce detectable signals accessible to measurement.	Detectable protein properties such as folding state, secondary/tertiary structure, enzymatic activity, ligand binding, PTM status, oligomerization, interaction networks, and conformational changes.
		Detection Limits	The boundaries of what can be resolved or sensed by current instruments or methods.	Lowest detectable protein concentrations, minimal resolvable structural features (Å resolution limits), smallest observable kinetic changes, fluorescence-intensity thresholds, and mass-spectrometry sensitivity limits for peptide identification or PTM detection.
	2.2 Measurement Systems	Units	Standardized quantifications (meters, seconds, volts, decibels, dollars, etc.) necessary for consistent comparison.	Mass (kDa), concentration (nM–µM), catalytic rates (kcat, Km), binding affinity (Kd), fluorescence intensity, circular-dichroism ellipticity, structural-resolution units (Å), and spectral absorbance.
		Instruments	Devices and tools (microscopes, spectrometers, sensors, surveys, detectors) used to produce measurements.	Mass spectrometers, HPLC systems, NMR spectrometers, X-ray crystallography, cryo-EM, fluorescence microscopes, spectrophotometers, plate readers, CD spectrometers, calorimeters (ITC/DSC), Western blot systems, and protein microarrays.
	2.3 Operational Definitions	Definitions	Terms defined by specific measurement procedures, ensuring empirical clarity.	Operational definitions of folded/unfolded states, catalytic activity, binding affinity, PTM presence, oligomeric state, and conformational transitions based on assay-specific thresholds and readouts.
		Procedures	The explicit steps required to perform a measurement in a reproducible way.	Standardized workflows such as protein purification, SDS-PAGE, Western blotting, enzyme-activity assays, co-immunoprecipitation, structural-determination pipelines, proteomics sample prep, and calorimetric binding measurements.
	2.4 Data Acquisition	Protocols	Formal processes for gathering data under controlled or standardized conditions.	Controlled protein-expression procedures, purification steps, kinetic-measurement cycles, crystallization trials, cryo-EM sample-prep protocols, mass-spec runs, and standardized replicates for quantitative assays.
		Sampling	Rules determining which subset of the domain is measured and how representative it is.	Rules for selecting protein variants, domains, conditions (temperature, pH), time points, interaction partners, or structural states to obtain representative biological protein behavior.
	2.5 Data Character & Format	Data Types	The form raw evidence takes (time series, spectra, images, counts, qualitative records).	Spectra (MS, NMR), diffraction patterns, EM density maps, kinetic time series, binding curves, electrophoretic band patterns, fluorescence traces, CD spectra, and peptide-sequence tables.
		Resolution	The granularity or precision with which data is captured.	Structural resolution (Å for EM/x-ray), time resolution for kinetic assays (ms–s), mass-spec resolution for peptide identification, and sensitivity limits for detecting rare conformational or PTM states.
	2.6 Reliability & Calibration	Calibration	Adjustment procedures ensuring instruments produce accurate results.	Calibration of spectrometers, plate readers, detectors, EM magnification, mass-spec mass accuracy, enzyme-activity standards, fluorescent probes, and baseline corrections in calorimetry and spectroscopy.
		Error Characterization	Identification and quantification of noise, uncertainty, bias, and measurement error.	Quantifying noise from detector drift, peptide-misidentification rates, sample degradation, purification contaminants, spectral overlap, electron-beam artifacts, kinetic measurement noise, and aggregation-induced variability.
3. Structural Layer	3.1 Patterns & Regularities	Laws / Relations	Stable, repeatable patterns governing how observables behave across conditions.	Sequence–structure–function relationships, folding–stability correlations, cooperative binding laws, catalytic rate rules, conserved structural motifs, and predictable thermodynamic behavior of protein folding.
		Invariants	Quantities or properties that remain constant under transformations (symmetries, conservation laws).	Conserved folds across species, stable domain architectures, catalytic triads, hydrophobic-core formation, invariant interaction motifs, and preservation of binding interfaces under evolutionary pressure.
	3.2 Causal Architecture	Mechanisms	Underlying processes or structures that produce the observed regularities.	Mechanisms include folding pathways, catalytic cycles, allosteric transitions, induced fit vs conformational selection, chaperone-assisted folding, PTM-driven activity shifts, and protein–protein interaction assembly.
		Pathways	Organized sequences of interactions forming a causal chain or network.	Ordered sequences such as synthesis → folding → modification → complex formation → functional action; or substrate binding → catalytic transition state → product release → enzyme reset; or misfold recognition → chaperone engagement → refolding or degradation.
	3.3 Theoretical Vocabulary	Concepts	Core terms that encode the domain’s structure (force, gene, equilibrium, field).	Core terms include primary/secondary/tertiary/quaternary structure, folding energy landscape, active site, allostery, catalytic efficiency, domains, motifs, PTMs, conformers, oligomerization, and binding affinity.
		Classifications	Taxonomies, categories, or typologies that organize entities and relations.	Structural classes (α-helix, β-sheet, mixed), functional protein families (enzymes, receptors, motors), fold families, domain architectures, PTM categories, complex types, and interaction-network classifications.
	3.4 Formal Representations	Equations	Mathematical constructs expressing laws, relations, or mechanisms.	Kinetic equations (Michaelis–Menten), thermodynamic folding equations (ΔG, ΔH, ΔS), binding-isotherm equations, rate laws for enzymatic cycles, statistical–mechanical models of conformational ensembles.
		Models	Structured representations—mathematical, computational, or conceptual—used to predict and explain phenomena.	Computational folding models, homology models, molecular dynamics simulations, coarse-grained interaction models, kinetic pathway models, docking models, and energetic landscape frameworks.
	3.5 Idealized Structures	Simplified Models	Purposeful abstractions that capture essential dynamics while omitting irrelevant detail.	Two-state folding models, rigid-body approximations, simplified interaction potentials, minimal catalytic mechanisms, coarse-grained residue models, and reduced PTM categories.
		Limit Conditions	Regimes where specific models or approximations hold (classical vs. quantum, linear vs. nonlinear).	Valid under moderate temperature, typical solvent conditions, and stable concentrations; break down under crowding, extreme pH, high temperature, denaturants, strong allosteric coupling, or multi-pathway folding behavior.
	3.6 Integrative Frameworks	Unifying Theories	Higher-order structures that connect disparate laws or mechanisms under a coherent whole.	Sequence→structure→function paradigm, thermodynamic folding framework, enzyme catalysis theory, allosteric regulation models, and protein-network integration across cellular pathways.
		Interdisciplinary Links	Points where the theory connects to adjacent sciences or larger explanatory systems.	Links to structural biology, biochemistry, molecular biology, biophysics, cell biology, pharmacology, and systems biology through shared principles of structure, kinetics, and interaction networks.
4. Method Layer	4.1 Inquiry Design	Experimental Design	Structured plans for manipulating variables to test causal claims.	Manipulating variables such as protein sequence, concentration, folding environment, ligand availability, PTM status, or binding partners through mutagenesis, controlled folding conditions, ligand titrations, or enzymatic modification.
		Observational Design	Systematic approaches for gathering non-manipulated data (surveys, field studies, natural experiments).	Non-manipulative approaches including measuring native protein structure, monitoring natural expression levels, mapping interaction networks, profiling PTMs, and observing spontaneous folding or aggregation behavior.
	4.2 Testing & Validation	Hypothesis Testing	Procedures for evaluating whether evidence supports or contradicts specific claims.	Testing claims about protein function, structural determinants, catalytic mechanisms, or interaction specificity through targeted assays, perturbation experiments, site-directed mutagenesis, or competitive binding studies.
		Replication	The requirement that results be independently reproducible under similar conditions.	Reproducing assays such as enzymatic kinetics, structural determinations (cryo-EM/x-ray/NMR), binding measurements, proteomics runs, and fluorescence-based conformational studies across independent replicates.
	4.3 Inference & Evaluation	Statistical Inference	Rules for drawing conclusions from noisy or incomplete data.	Inferring protein behavior from noisy spectral, structural, or kinetic data using statistical models, error propagation, confidence intervals, ensemble averaging, and Bayesian structural or interaction-inference methods.
		Model Comparison	Criteria (fit, simplicity, predictive accuracy, robustness) used to evaluate competing models.	Evaluating alternative folding models, kinetic models, interaction hypotheses, and structural predictions based on fit to empirical data, predictive success, stability under parameter variation, and cross-method consistency.
	4.4 Error Management	Error Analysis	Identification and quantification of random and systematic errors.	Quantifying noise from detector drift, sample degradation, mass-spec misidentification, spectral overlap, crystallographic noise, kinetic-measurement variability, and misfold-related artifacts.
		Bias Control	Methods for minimizing subjective, instrumental, or procedural biases.	Reducing bias through standardized protein-purification workflows, balanced sample preparation, validated antibodies and reagents, randomized measurement order, and calibrated structural/imaging conditions.
	4.5 Adjudication & Revision	Peer Scrutiny	Collective evaluation of claims through critique, review, and debate.	Independent evaluation of structural claims, functional interpretations, kinetic models, interaction networks, and proteomics analyses through peer review, cross-validation, and collaborative replication.
		Theory Revision	Procedures for modifying, replacing, or discarding models based on new evidence.	Updating models of protein folding, enzyme mechanisms, interactions, allostery, or PTM effects when new structural data, kinetic results, or functional observations contradict existing frameworks.
	4.6 Integrity Conditions	Transparency	Requirements to disclose methods, data, assumptions, and limitations.	Full reporting of purification methods, sample conditions, structural-determination parameters, kinetic protocols, calibration steps, modeling assumptions, and data-processing pipelines.
		Ethical Standards	Norms ensuring responsible conduct in experimentation, data handling, and publication.	Responsible conduct in protein experimentation, accurate reporting of results, avoidance of selective data presentation, proper handling of recombinant or engineered proteins, and adherence to biosafety and research-integrity standards.